Survival factors for treatment of retinal degenerative disorders: preclinical gains and issues for translation into clinical studies.
Lavail
Matthew M
MM
Anatomy and Ophthalmology at the University of California, San Francisco School of Medicine, San Francisco, CA, USA.
D000818:Animals; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009414:Nerve Growth Factors / Q000627:therapeutic use* / Q000633:toxicity; D012162:Retinal Degeneration / Q000188:drug therapy*
D009414:Nerve Growth Factors